Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- The University of Arizona
- Aarhus University
- Yale University
- University of Washington
- King's College London
- Lawrence Berkeley National Laboratory
- The Ohio State University
- University of Miami
- AALTO UNIVERSITY
- Argonne
- Baylor College of Medicine
- Bundesanstalt für Materialforschung und -prüfung (BAM)
- Cornell University
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- Duke University
- Durham University
- ETH Zürich
- Forschungszentrum Jülich
- GSI Helmholtzzentrum für Schwerionenforschung
- ICN2
- InLife Institute of Animal Reproduction and Food Research, Polish Academy of Sciences
- Institut Pasteur
- Institute for bioengineering of Catalonia, IBEC
- Karolinska Institutet (KI)
- Lehigh University
- MOHAMMED VI POLYTECHNIC UNIVERSITY
- Macquarie University
- Massachusetts Institute of Technology
- Mossakowski Medical Research Institute, Polish Academy of Sciences
- Northeastern University
- Rutgers University Shumyatsky lab
- St Jude Children's Research Hospital
- Stony Brook University
- TTI
- The University of Iowa
- University of Basel
- University of Florida
- University of Glasgow
- University of Luxembourg
- University of North Carolina at Chapel Hill
- University of North Carolina at Charlotte
- University of Oregon
- University of Oslo
- University of Oxford
- University of Sydney
- University of Turku
- Virginia Tech
- Washington University in St. Louis
- Wayne State University
- 39 more »
- « less
-
Field
-
Centre of Excellence in Restorative Neural Dynamics (CoRE RND) and the Brain Network Dynamics Unit (BNDU), a division of NDCN. The Group has a strong track record in of executing translational studies
-
samples. The lab seeks to uncover new therapeutic targets in cancer by bridging single-cell sequencing with high-throughput immune/cancer cell co-culture screens (PMID: 33483338, PMID: 40799546, PMID
-
Title of the Position: Postdoctoral Associate in Pharmacoepidemiology: Drug Repurposing and Target Trial Emulations in Addiction Department and School: Department of Internal Medicine, Yale School
-
for this position will facilitate DoW funded project on the development of targeted PIM Kinase inhibitor PROTACs and their nanomedicines and also assist the Principal Investigator, Dr. Abhijit Date, in developing new
-
Deutsches Zentrum für Neurodegenerative Erkrankungen | Magdeburg, Sachsen Anhalt | Germany | 11 days ago
student track are equally welcome; requirements will be considered relative to career stage Your role in cutting edge research Disease-targeting treatments for Alzheimer's disease work best when
-
homeostasis in brain physiology and how its disruption impairs neuronal biology, ultimately, to identify novel therapeutic targets. To learn more about our research and collaborations, visit https
-
detailing your expertise and motivation for applying Department Summary The Knight Campus for Accelerating Scientific Impact is an ambitious initiative designed to fast-track scientific discoveries
-
scientific writing skills, with a track record of publications in peer-reviewed journals. Ability to work independently and collaboratively in a team environment. Minimum Qualifications PhD, MD, or other
-
biology, mitochondrial biology, and neuro-immune signaling, with the long-term goal of developing new therapeutic targets for gut motility disorders and peripheral neuropathies. The laboratory is cross
-
Job Description Apply now Job Title: Postdoctoral Associate - Targeted Protein Degradation Division: Pathology Work Arrangement: Onsite only Location: Houston, TX Salary Range: $62,232 FLSA Status